Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80

By Weiss Anna   Noorbaksh Abraham   Tokin Christopher   Chang David   Blair Sarah  

Annals of Surgical Oncology, Vol. 20, Iss. 10, 2013-10 ,pp. : 3274-3278

Springer Publishing Company

Access to resources Recommend Favorite

DNA repair signature is associated with anthracycline response in triple negative breast cancer patients

By Rodriguez A.  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 189-196

Springer Publishing Company

Access to resources Recommend Favorite

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

By Rahko E.   Blanco G.   Soini Y.   Bloigu R.   Jukkola A.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 447-453

Elsevier

Access to resources Recommend Favorite

Serum folliclestimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in postmenopausal females with breast cancer

By            

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 1128-1132

Spandidos Publications

Access to resources Recommend Favorite

Dermcidin expression is associated with disease progression and survival among breast cancer patients

By Brauer Heather   D’Arcy Monica   Libby Tanya   Thompson Henry   Yasui Yutaka   Hamajima Nobuyuki   Li Christopher   Troester Melissa   Lampe Paul  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 299-306

Springer Publishing Company

Access to resources Recommend Favorite